Pfizer Licensing, Development & Alliances
Compound Transfer Program

Pfizer has an extensive pure powder transfer program that encompasses all of our publicly known compounds. We review each request regarding use of our compounds for content, value, and consistency with Pfizer's direction for the requested compound. We routinely enter Compound Transfer Agreements (CTAs) that provide the compound free of charge to a third party to conduct the agreed upon study. We require a manuscript or report of the conclusions to bring closure to the study. Pfizer reserves the right to deny any request that we feel does not advance our compound(s) or add value to human or animal health.

To request a Pfizer compound please complete this compound request form. This form will provide Pfizer with the minimum information required to issue our CTA. Along with the CTA, a Statement of Investigation (SOI) will be enclosed. The SOI needs to be a specific and detailed description of your proposed study, as we rely on it to review and approve or deny your request. From initial contact to the approved compound(s) arriving at your facility is normally 12 weeks.

Please return the compound request form here for processing:

Donnie W. Owens
Pfizer Compound Transfer Manager
Worldwide Strategic Alliances
Pfizer Inc
MS 8200-30
Eastern Point Road
Groton, CT 06340